Skip to main content

Natural Alternatives International, Inc.

corporate_fare Company Profile

Natural Alternatives International, Inc.

NAII·NASDAQ·Life Sciences·CIK 0000787253

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance.In addition, the company sells beta-alanine ingredient under the CarnoSyn, TriBsynm, and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

Natural Alternatives International, Inc. (NASDAQ:NAII) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 8 items for NAII at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 7/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for NAII spans 10-Q, 10-K, 8-K.

Recent high-impact activity:

  • Natural Alternatives Posts $2.48M Q1 Loss as Sales Slide 25%
  • NAII Q1 Sales Fall 25%, Covenant Breached; $10M Debt Now Current
  • NAII Posts $13.5M Q4 Loss, $10.4M Impairment, and Explores Sale
  • NAII 10-K: Going Concern Warning, Covenant Breach Forecast, and $10.4M Impairment
  • Secures $31M High-Interest Debt, Plans HQ Sale Amid Deepening Losses

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$142.51M
Net Income
-$20.7M
Diluted EPS
-$3.43
Op. Cash Flow
-$8.92M
Free Cash Flow
-$12.62M
Gross Profit
$9M
Operating Income
-$18.75M
Cash & Equivalents
$7.39M
Debt / Equity
0.00×
Net Margin
-14.5%
Shares Outstanding
6.27M sh
Source: 10-K · filed 2026-09-28 · accession 0001437749-26-031343

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 5,308 shares in NAII as of the October 30, 2026 settlement, a 23.6% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 23.7% of NAII volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)5,308 shares as of October 30, 2026
Change vs prior period▲ 23.6%
Days to cover1.00 at avg daily volume of 15,638
Daily short volume (FINRA facilities)23.7% of 7,161 shares on November 20, 2026
5-day average short volume11.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with N →
$0.90
52-week range · as of 2026-11-13 $0.90 – $4.96
Market cap
$5.48M
Volume
12.7K (0.8× avg)
3-mo avg 16.6K
Live data · 2026-11-21 14:30 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NAII - Latest Insights

NAII
Nov 13, 2026, 4:30 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.9666
Real-time Price: $0.900 info
Change: -$0.0666 (-7%) info
Market Cap: $5.483M info
NAII
Nov 13, 2026, 4:16 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.9666
Real-time Price: $0.900 info
Change: -$0.0666 (-7%) info
Market Cap: $5.483M info
NAII
Sep 28, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.70
Real-time Price: $0.900 info
Change: -$0.800 (-47%) info
Market Cap: $5.483M info
NAII
Sep 28, 2026, 4:16 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.70
Real-time Price: $0.900 info
Change: -$0.800 (-47%) info
Market Cap: $5.483M info
NAII
May 19, 2026, 6:03 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.59
Real-time Price: $0.900 info
Change: -$1.69 (-65%) info
Market Cap: $5.483M info
NAII
May 01, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.72
Real-time Price: $0.900 info
Change: -$1.82 (-67%) info
Market Cap: $5.483M info
NAII
Mar 20, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.56
Real-time Price: $0.900 info
Change: -$1.66 (-65%) info
Market Cap: $5.483M info
NAII
Feb 13, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.49
Real-time Price: $0.900 info
Change: -$2.59 (-74%) info
Market Cap: $5.483M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets